PharVision Advisers’s Littelfuse LFUS Stock Holding History

PharVision Advisers’s Portfolio LFUS Stock Details LFUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-905	Closed	-$234K	–	867
2025 Q3	$234K	Buy	+905	New	+$227K	0.13%	380

Other funds holding LFUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's LFUS Position: Q4 2025 in Review

PharVision Advisers sold out of Littelfuse (LFUS) in Q4 2025, closing a stake of 905 shares — an estimated $234K sold.

PharVision Advisers first reported a position in LFUS in Q3 2025 and held it in 1 quarter. The position peaked at $234K in Q3 2025. 470 funds tracked by Wall St. Rank hold LFUS as of Q4 2025.

PharVision Advisers reported no remaining Littelfuse position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 905 Littelfuse shares in Q4 2025, an estimated $234K.
PharVision Advisers first reported a position in Littelfuse in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Littelfuse position peaked at $234K in Q3 2025.
470 funds tracked by Wall St. Rank held Littelfuse as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.